Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Forbes

Showing results (221-230 of 309) with videos related to

Pageof 31
Sort By:
Cryobiology|January 26, 2012
Cryoprotective agent toxicity interactions in human articular chondrocytesK A Almansoori, V Prasad, J F Forbes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2011
Risk of recurrence and chemotherapy benefit for patients with node-negative, estrogen receptor-positive breast cancer: recurrence score alone and integrated with pathologic and clinical factorsGong Tang, Jack Cuzick, Joseph P Costantino, et al.
Health Technology Assessment (Winchester, England)|March 24, 2010
Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trialA W Bradbury, D J Adam, J Bell, et al.
The British Journal of Surgery|May 22, 2007
Final 12-year follow-up of surgery versus surveillance in the UK Small Aneurysm TrialJ T Powell, L C Brown, J F Forbes, et al.
Journal of Toxicology and Environmental Health|August 30, 1996
Speciation of aluminum in biological systemsW R Harris, G Berthon, J P Day, et al.
Journal of Vascular Surgery|May 4, 2010
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A description of the severity and extent of disease using the Bollinger angiogram scoring method and the TransAtlantic Inter-Society Consensus II classificationAndrew W Bradbury, Donald J Adam, Jocelyn Bell, et al.
Journal of Vascular Surgery|May 4, 2010
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Health-related quality of life outcomes, resource utilization, and cost-effectiveness analysisJohn F Forbes, Donald J Adam, Jocelyn Bell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2009
Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancerM D Green, P A Francis, V Gebski, et al.
Journal of Vascular Surgery|May 4, 2010
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A survival prediction model to facilitate clinical decision makingAndrew W Bradbury, Donald J Adam, Jocelyn Bell, et al.
British Journal of Cancer|June 4, 2014
Improving decision making about clinical trial participation - a randomised controlled trial of a decision aid for women considering participation in the IBIS-II breast cancer prevention trialI Juraskova, P Butow, C Bonner, et al.
Pageof 31

Showing results (221-230 of 309) with videos related to

Sort By:
Pageof 31
Cryobiology|January 26, 2012
Cryoprotective agent toxicity interactions in human articular chondrocytesK A Almansoori, V Prasad, J F Forbes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2011
Risk of recurrence and chemotherapy benefit for patients with node-negative, estrogen receptor-positive breast cancer: recurrence score alone and integrated with pathologic and clinical factorsGong Tang, Jack Cuzick, Joseph P Costantino, et al.
Health Technology Assessment (Winchester, England)|March 24, 2010
Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trialA W Bradbury, D J Adam, J Bell, et al.
The British Journal of Surgery|May 22, 2007
Final 12-year follow-up of surgery versus surveillance in the UK Small Aneurysm TrialJ T Powell, L C Brown, J F Forbes, et al.
Journal of Toxicology and Environmental Health|August 30, 1996
Speciation of aluminum in biological systemsW R Harris, G Berthon, J P Day, et al.
Journal of Vascular Surgery|May 4, 2010
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A description of the severity and extent of disease using the Bollinger angiogram scoring method and the TransAtlantic Inter-Society Consensus II classificationAndrew W Bradbury, Donald J Adam, Jocelyn Bell, et al.
Journal of Vascular Surgery|May 4, 2010
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Health-related quality of life outcomes, resource utilization, and cost-effectiveness analysisJohn F Forbes, Donald J Adam, Jocelyn Bell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2009
Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancerM D Green, P A Francis, V Gebski, et al.
Journal of Vascular Surgery|May 4, 2010
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A survival prediction model to facilitate clinical decision makingAndrew W Bradbury, Donald J Adam, Jocelyn Bell, et al.
British Journal of Cancer|June 4, 2014
Improving decision making about clinical trial participation - a randomised controlled trial of a decision aid for women considering participation in the IBIS-II breast cancer prevention trialI Juraskova, P Butow, C Bonner, et al.
Pageof 31